Quinolone-induced cartilage lesions are not reversible in rats

Archives of Toxicology

Volumn 70, Issue 8, 1996, Pages 474-481

  Förster, Christian ^a   Kociok, Katja ^a   Shakibaei, Mehdi ^a   Merker, Hans Joachim ^a   Stahlmann, Ralf ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cartilage lesions; Quinolone; Rat

Indexed keywords

GLYCOSAMINOGLYCAN; OFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; BONE LESION; CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; FEMALE; HISTOLOGY; INTRAGASTRIC DRUG ADMINISTRATION; JUVENILE; KNEE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; CARTILAGE; CARTILAGE DISEASES; FEMALE; MALE; OFLOXACIN; RATS; TIME FACTORS;

EID: 0029928941     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050301     Document Type: Article

References (27)

1. Adam D (1989) Use of quinolones in pediatric patients. Rev Infect Dis 11 [suppl. 5]: S1113-S1116
2. Alfaham M, Holt ME, Goodchild MC (1987) Arthropathy in a patient with cystic fibrosis. BMJ 295: 699
3. Bendele AM, Hulman JF, Harvey AK, Hrubey PS, Chandrasekhar S (1990) Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicol Pathol 18: 304-312
4. Biswal N, Mathai B, Bhatia BD (1993) P-floxacin induced arthropathy. Ind Pediatr 30: 718-719
5. Bourke S, Rooney M, Fitzgerald M, Bresnihan B (1987) Episodic arthropathy in adult cystic fibrosis. Q J Med 64: 651-659
6. Burkhardt JE, Hill MA, Carlton WW, Kesterson JW (1990) Histologic and histochemical changes in articular cartilage of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 27: 162-170
7. Burkhardt JE, Hill MA, Turek JJ, Carlton WW (1992) Ultrastructural changes in articular cartilage of immature beagle dogs dosed with ditloxacin, a fluoroquinolone. Vet Pathol 29: 230-238
8. Chevalier X, Albengres E, Voisin MC, Tillement JP, Larget-Piet B (1992) A case of destructive polyarthropathy in a 17-year-old youth following perfloxacin treatment. Drug Safety 7: 310-314
9. Chysky V, Kapila K, Hullmann R, Arcieri G, Schacht P, Echols R (1991) Safety of ciprotloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 19: 289-296
10. Förster C, Kociok K, Shakibaci M, Merker HJ, Vormann J, Günther T, Stahlmann R (1996) Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch Toxicol 70: 261-270
11. Gough AW, Kasali OB, Siegler RE, Baragi V (1992) Quinolone arthropathy-acute toxicity to immature cartilage. Toxicol Pathol 20: 436-450
12. Ingham B, Brentnall DW, Dale EA, MacFadzean JA (1977) Arthropathy induced by antibacterial fused N-alkyl-3-pyridonecarboxylic acids. Toxicol Lett 1: 21-26
13. Kato M, Onodera T (1988a) Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fundam Appl Toxicol 11: 110-119
14. Kato M, Onodera T (1988b) Morphological investigation of osteochondrosis induced by ofloxacin in rats. Fundam Appl Toxicol 11: 120-131
15. Kato M, Takada S, Ogawara S, Takayama S (1995) Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo. Antimicrob Agents Chemother 39: 1979-1983
16. Lode H, Höffken G, Olschewski P, Sievers B, Kirch A, Borner K, Koeppe P (1987) Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother 31: 1338-1342
17. Machida M, Kusajima H, Aijima H, Maeda A, Ishida R, Uchida H (1990) Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 105: 403-412
18. Meissner A, Borner K, Koeppe P (1990) Concentrations of ofloxacin in human bone and cartilage. J Antimicrob Chemother 26 [Suppl D]: 69-74
19. Pertuiset E, Lenoir G, Jehanne M, Douchan F, Guillot M, Menkes CJ (1989) Tolérance articulaire de la pefloxacine et de l'ofloxacine chez les enfants et adolescants atteints de mucoviscidose. Rev Rhum 56: 735-740
20. Samuelson WM, Pleasants RA, Whitaker MS (1993) Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. Ann Pharmacother 27: 302-3034
21. Schaad UB, Wedgwood-Krucko J (1987) Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 15: 165-168
22. Schaad UB, Wedgwood J (1992) Lack of quinolone-induced arthropathy in children. J Antimicrob Chemother 30: 414-415
23. Schlüter G (1986) Toxicology of ciprofloxacin. In: Neu HC, Weuta H (eds) First International Ciprofloxacin Workshop. Proc Excerpta Medica, pp 61-70
24. Stahlmann R, Merker HJ, Hinz N, Webb J, Heger W, Neubert D (1990) Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol 64: 193-204
25. Stahlmann R, Förster C, Van Sickle D (1993) Quinolones in children. Are concerns over arthropathy justified? Drug Safety 9: 397-403
26. Stahlmann R, Förster C, Shakibaei M, Vormann J, Günther T, Merker HJ (1995) Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical with quinolone-induced arthropathy. Antimicrob Agents Chemother 39: 2013-2018
27. Tatsumi H, Senda H, Yatera S, Takemoto Y, Yamayoshi M, Ohnishi K (1978) Toxicological studies on pipemidic acid V. Effect on diarthrodial joints of experimental animals. J Toxicol Sci 3: 357-367